Marketing Medical Devices Without the FDA Risk

One warning letter can force you to pull your entire marketing program overnight. We build medical device marketing that is aggressive enough to win market share and compliant enough to keep your regulatory team comfortable.

Why This Matters

FDA enforcement of medical device marketing is not theoretical. Warning letters are issued regularly to companies making unsupported claims, using incorrect regulatory status language, or promoting off-label uses in their marketing materials. The consequences are real: forced removal of content, required corrective advertising, import holds, and in serious cases, consent decrees that put FDA oversight on every piece of promotional material you produce.

Most marketing agencies do not understand these constraints. They write compelling copy that makes claims your 510(k) does not support. They use testimonials that describe off-label use. They design comparison charts that imply superiority without clinical evidence. The marketing looks great -- until your regulatory team kills it or, worse, until the FDA notices.

We have spent 18 years creating marketing for medical device companies. Regulatory awareness is not a service we bolt on -- it is embedded in how we create every piece of content, every website, and every campaign.

What We Do

Claims Review Against 510(k) Clearance

Every marketing claim we develop is checked against your device's specific 510(k) clearance letter, indications for use statement, and predicate device history. We identify claims that are supported, claims that need modification, and claims that should not be made. This happens during content creation, not after -- which means fewer revision cycles and faster time to market.

Clinical Data Substantiation

When you want to make performance claims, we help determine what your clinical data actually supports. This includes reviewing published studies, internal clinical data, post-market surveillance data, and adverse event history. We draft claims that maximize marketing impact within the boundaries of your evidence base.

Comparative Advertising Compliance

Comparison to competitors is one of the most effective marketing tactics -- and one of the most regulated. We develop comparative content that uses published specifications, peer-reviewed clinical data, and cleared claims only. No implied superiority without evidence. No cherry-picked data points. Comparisons that are defensible if challenged by a competitor or regulator.

Promotional Material Review

We review existing marketing materials -- websites, brochures, sell sheets, presentations, social media, trade show materials -- for potential regulatory issues. The audit identifies specific problems, prioritizes them by risk level, and provides recommended corrections for each item. Many clients are surprised by what they find in materials they have been using for years.

Common Mistakes in Medical Device Marketing

These errors trigger FDA enforcement actions regularly

We see these issues in the majority of medical device marketing materials we audit. Each one represents a potential regulatory risk.

"FDA Cleared" vs. "FDA Approved" -- Why It Matters in Your Copy

This is the single most common error we see in medical device marketing, and it matters more than most companies realize. The 510(k) pathway (clearance) demonstrates substantial equivalence to a predicate device. The PMA pathway (approval) requires clinical trials demonstrating safety and efficacy. Using the wrong term is not just technically incorrect -- it misrepresents your device's regulatory status to buyers, which is exactly the kind of issue that triggers FDA enforcement.

Beyond compliance, sophisticated buyers -- hospital procurement teams, GPO evaluators, and experienced surgeons -- notice when you get this wrong. It signals that your marketing team does not understand the regulatory landscape, which raises questions about what else you might be getting wrong.

We build the correct regulatory language into every piece of content we create, and we check existing materials for this error in every audit.

Frequently Asked Questions

What is the difference between FDA cleared and FDA approved?

FDA cleared means a device has gone through the 510(k) premarket notification process, demonstrating substantial equivalence to a legally marketed predicate device. FDA approved means a device has gone through the more rigorous Premarket Approval (PMA) process with clinical trials demonstrating safety and efficacy. Most Class II medical devices are 510(k) cleared, not approved. Using "FDA approved" when your device is actually 510(k) cleared is a common marketing error that can trigger FDA enforcement action. Your marketing materials should use the correct term for your device's regulatory pathway.

Can we use surgeon testimonials in our medical device marketing?

Yes, but with specific constraints. Surgeon testimonials must reflect the device's cleared indications for use. A testimonial cannot describe off-label use, make comparative superiority claims without clinical data, or imply outcomes beyond what your clinical evidence supports. Testimonials from paid consultants should include appropriate disclosure. We structure testimonial programs to capture compelling surgeon perspectives while staying within FDA promotional guidelines.

How do I know if our current marketing materials are FDA compliant?

We offer marketing material audits where we review your existing promotional content against your 510(k) clearance, available clinical data, and current FDA guidance documents. We check for common issues: off-label claims, unsubstantiated performance comparisons, misuse of regulatory status language, and missing required disclosures. The audit produces a prioritized report of issues with specific recommendations for each piece of content.

What happens if FDA sends a warning letter about our marketing?

An FDA warning letter requires a formal response within 15 business days. The immediate priority is removing or correcting the violative materials. This can mean pulling website content, brochures, social media posts, and any other promotional materials cited in the letter. Beyond the immediate response, you need to review all remaining marketing materials for similar issues and implement a compliant review process going forward. Prevention is far less expensive than remediation -- which is why we build regulatory review into the content creation process from the start.

Market Aggressively. Stay Compliant.

Get a regulatory marketing audit or talk to us about building compliant campaigns from scratch.

Schedule a Review